Fluorescence-guidance in non-Gadolinium enhancing, but FET-PET positive gliomas

Schebesch, Karl-Michael and Brawanski, Alexander and Doenitz, Christian and Rosengarth, Katharina and Proescholdt, Martin and Riemenschneider, Markus J. and Grosse, Jirka and Hellwig, Dirk and Hoehne, Julius (2018) Fluorescence-guidance in non-Gadolinium enhancing, but FET-PET positive gliomas. CLINICAL NEUROLOGY AND NEUROSURGERY, 172. pp. 177-182. ISSN 0303-8467, 1872-6968

Full text not available from this repository. (Request a copy)

Abstract

Objectives: We report on five patients with gadolinium-negative (non-enhancing magnetic resonance imaging-MRI) but F-18-fluoroethyl tyrosine positron-emission tomography (FET-PET) positive glioma (NEG) undergoing surgery under fluorescence-guidance with fluorescein sodium 10% (FL, Alkon, Germany) in combination with a dedicated light filter (YELLOW 560 nm, Carl Zeiss Meditec, Germany). Patients and method: Since 2017, five patients (3 female, 2 male; mean age 45.4 years) underwent fluorescence guided surgery for supratentorial, intracerebral lesions which showed no contrast-enhancement in the preoperative MRI but were, however, strongly suspicious for gliomas. Accordingly, all patients received a preoperative FET-PET scan and detailed histopathological workup was performed. After giving written informed consent, all patients received 5 mg/kg of FL at the induction of anesthesia. Surgery was conducted under white light and under the YELLOW 560 nm filter. We reviewed the surgical protocols, navigational storage and the image databases of our surgical microscopes for evidence of intraoperative fluorescence that corresponded to the FET-PET positive area. Results: In all patients we found distinct accordances between the FET-PET positive areas and the fluorescing regions within the targeted lesions. Histopathological workup of the fluorescent tissue revealed anaplastic oligodendroglioma, IDH-mutant and 1p/19-codeleted (WHO grade III) (n = 2), anaplastic astrocytoma, IDH-mutant (WHO grade III) (n = 1), oligodendroglioma, IDH-mutant and 1p/19q-codeleted (WHO grade II) (n = 1) and pilocytic astrocytoma (WHO grade I) (n = 1). No adverse events were noted. Discussion and conclusion: Despite the lack of gadolinium-enhancement in the preoperative MRI, all patients intravenously received FL to guide resection. Irrespective of the final grading, FL was extremely helpful in detecting the lesions and in identifying their border zones. In selected patients with NEG, but strong metabolic activity according to the FET-PET, FL may significantly increase the accuracy of surgery.

Item Type: Article
Uncontrolled Keywords: LOW-GRADE GLIOMAS; GUIDED SURGERY; RESECTION; PERFORMANCE; MICROSCOPE; F-18-FET; Low grade glioma; Fluorescence-guided surgery; Fluorescein sodium; FET-PET; FDG-PET-CT; Pilocytic astrocytoma; Oligodendroglioma; Anaplastic astrocytoma; YELLOW 560 nm filter
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Neurochirurgie
Medicine > Abteilung für Neuropathologie
Medicine > Lehrstuhl für Strahlentherapie
Depositing User: Dr. Gernot Deinzer
Date Deposited: 08 Jan 2020 15:08
Last Modified: 08 Jan 2020 15:08
URI: https://pred.uni-regensburg.de/id/eprint/13902

Actions (login required)

View Item View Item